aluates Reports

$ 0.0

Automative

Global Urinary Follicle Stimulating Hormone Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-15A8069

Global Urinary Follicle Stimulating Hormone Market Insights Forecast to 2028

BUY CHAPTERS

Global Urinary Follicle Stimulating Hormone Market Research Report 2025

Code: QYRE-Auto-15A8069

Report

July 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

IBSA

Ferring

LIVZON

Urinary Follicle Stimulating Hormone Market Size

The global market for Urinary Follicle Stimulating Hormone was valued at US$ 253 million in the year 2024 and is projected to reach a revised size of US$ 369 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Urinary Follicle Stimulating Hormone Market

FSH levels are higher in women who are menopausal making their urine a good source for extraction. Pergonal also contains leutinizing hormone (LH) which produces many effects including higher estrogen levels. So, FSH can be extracted from urine.

North American market for Urinary Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Urinary Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Urinary Follicle Stimulating Hormone include IBSA, Ferring, Livzon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urinary Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Follicle Stimulating Hormone.

The Urinary Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urinary Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urinary Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Urinary Follicle Stimulating Hormone Market Report

Report Metric	Details
Report Name	Urinary Follicle Stimulating Hormone Market
Accounted market size in year	US$ 253 million
Forecasted market size in 2031	US$ 369 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	75IU 150IU Others
Segment by Application	Infertility Treatment Assisted Reproductive Technology
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	IBSA, Ferring, Livzon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urinary Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urinary Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Urinary Follicle Stimulating Hormone Market growing?

Ans: The Urinary Follicle Stimulating Hormone Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Urinary Follicle Stimulating Hormone Market size in 2031?

Ans: The Urinary Follicle Stimulating Hormone Market size in 2031 will be US$ 369 million.

Who are the main players in the Urinary Follicle Stimulating Hormone Market report?

Ans: The main players in the Urinary Follicle Stimulating Hormone Market are IBSA, Ferring, Livzon

What are the Application segmentation covered in the Urinary Follicle Stimulating Hormone Market report?

Ans: The Applications covered in the Urinary Follicle Stimulating Hormone Market report are Infertility Treatment, Assisted Reproductive Technology

What are the Type segmentation covered in the Urinary Follicle Stimulating Hormone Market report?

Ans: The Types covered in the Urinary Follicle Stimulating Hormone Market report are 75IU, 150IU, Others

Recommended Reports

Hormone & Fertility Markets

Urinary Health & Treatments

Reproductive & Endocrine Devices

1 Urinary Follicle Stimulating Hormone Market Overview

1.1 Product Definition

1.2 Urinary Follicle Stimulating Hormone by Type

1.2.1 Global Urinary Follicle Stimulating Hormone Market Value Comparison by Type (2024 VS 2031)

1.2.2 75IU

1.2.3 150IU

1.2.4 Others

1.3 Urinary Follicle Stimulating Hormone by Application

1.3.1 Global Urinary Follicle Stimulating Hormone Market Value by Application (2024 VS 2031)

1.3.2 Infertility Treatment

1.3.3 Assisted Reproductive Technology

1.4 Global Urinary Follicle Stimulating Hormone Market Size Estimates and Forecasts

1.4.1 Global Urinary Follicle Stimulating Hormone Revenue 2020-2031

1.4.2 Global Urinary Follicle Stimulating Hormone Sales 2020-2031

1.4.3 Global Urinary Follicle Stimulating Hormone Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Urinary Follicle Stimulating Hormone Market Competition by Manufacturers

2.1 Global Urinary Follicle Stimulating Hormone Sales Market Share by Manufacturers (2020-2025)

2.2 Global Urinary Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Urinary Follicle Stimulating Hormone Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Urinary Follicle Stimulating Hormone, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Product Type & Application

2.7 Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Date of Enter into This Industry

2.8 Global Urinary Follicle Stimulating Hormone Market Competitive Situation and Trends

2.8.1 Global Urinary Follicle Stimulating Hormone Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Urinary Follicle Stimulating Hormone Players Market Share by Revenue

2.8.3 Global Urinary Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Urinary Follicle Stimulating Hormone Market Scenario by Region

3.1 Global Urinary Follicle Stimulating Hormone Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Urinary Follicle Stimulating Hormone Sales by Region: 2020-2031

3.2.1 Global Urinary Follicle Stimulating Hormone Sales by Region: 2020-2025

3.2.2 Global Urinary Follicle Stimulating Hormone Sales by Region: 2026-2031

3.3 Global Urinary Follicle Stimulating Hormone Revenue by Region: 2020-2031

3.3.1 Global Urinary Follicle Stimulating Hormone Revenue by Region: 2020-2025

3.3.2 Global Urinary Follicle Stimulating Hormone Revenue by Region: 2026-2031

3.4 North America Urinary Follicle Stimulating Hormone Market Facts & Figures by Country

3.4.1 North America Urinary Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Urinary Follicle Stimulating Hormone Sales by Country (2020-2031)

3.4.3 North America Urinary Follicle Stimulating Hormone Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Urinary Follicle Stimulating Hormone Market Facts & Figures by Country

3.5.1 Europe Urinary Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Urinary Follicle Stimulating Hormone Sales by Country (2020-2031)

3.5.3 Europe Urinary Follicle Stimulating Hormone Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Urinary Follicle Stimulating Hormone Market Facts & Figures by Region

3.6.1 Asia Pacific Urinary Follicle Stimulating Hormone Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Urinary Follicle Stimulating Hormone Sales by Region (2020-2031)

3.6.3 Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Urinary Follicle Stimulating Hormone Market Facts & Figures by Country

3.7.1 Latin America Urinary Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Urinary Follicle Stimulating Hormone Sales by Country (2020-2031)

3.7.3 Latin America Urinary Follicle Stimulating Hormone Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Urinary Follicle Stimulating Hormone Market Facts & Figures by Country

3.8.1 Middle East and Africa Urinary Follicle Stimulating Hormone Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2020-2031)

3.8.3 Middle East and Africa Urinary Follicle Stimulating Hormone Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Urinary Follicle Stimulating Hormone Sales by Type (2020-2031)

4.1.1 Global Urinary Follicle Stimulating Hormone Sales by Type (2020-2025)

4.1.2 Global Urinary Follicle Stimulating Hormone Sales by Type (2026-2031)

4.1.3 Global Urinary Follicle Stimulating Hormone Sales Market Share by Type (2020-2031)

4.2 Global Urinary Follicle Stimulating Hormone Revenue by Type (2020-2031)

4.2.1 Global Urinary Follicle Stimulating Hormone Revenue by Type (2020-2025)

4.2.2 Global Urinary Follicle Stimulating Hormone Revenue by Type (2026-2031)

4.2.3 Global Urinary Follicle Stimulating Hormone Revenue Market Share by Type (2020-2031)

4.3 Global Urinary Follicle Stimulating Hormone Price by Type (2020-2031)

5 Segment by Application

5.1 Global Urinary Follicle Stimulating Hormone Sales by Application (2020-2031)

5.1.1 Global Urinary Follicle Stimulating Hormone Sales by Application (2020-2025)

5.1.2 Global Urinary Follicle Stimulating Hormone Sales by Application (2026-2031)

5.1.3 Global Urinary Follicle Stimulating Hormone Sales Market Share by Application (2020-2031)

5.2 Global Urinary Follicle Stimulating Hormone Revenue by Application (2020-2031)

5.2.1 Global Urinary Follicle Stimulating Hormone Revenue by Application (2020-2025)

5.2.2 Global Urinary Follicle Stimulating Hormone Revenue by Application (2026-2031)

5.2.3 Global Urinary Follicle Stimulating Hormone Revenue Market Share by Application (2020-2031)

5.3 Global Urinary Follicle Stimulating Hormone Price by Application (2020-2031)

6 Key Companies Profiled

6.1 IBSA

6.1.1 IBSA Company Information

6.1.2 IBSA Description and Business Overview

6.1.3 IBSA Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)

6.1.4 IBSA Urinary Follicle Stimulating Hormone Product Portfolio

6.1.5 IBSA Recent Developments/Updates

6.2 Ferring

6.2.1 Ferring Company Information

6.2.2 Ferring Description and Business Overview

6.2.3 Ferring Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Ferring Urinary Follicle Stimulating Hormone Product Portfolio

6.2.5 Ferring Recent Developments/Updates

6.3 Livzon

6.3.1 Livzon Company Information

6.3.2 Livzon Description and Business Overview

6.3.3 Livzon Urinary Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Livzon Urinary Follicle Stimulating Hormone Product Portfolio

6.3.5 Livzon Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Urinary Follicle Stimulating Hormone Industry Chain Analysis

7.2 Urinary Follicle Stimulating Hormone Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Urinary Follicle Stimulating Hormone Production Mode & Process Analysis

7.4 Urinary Follicle Stimulating Hormone Sales and Marketing

7.4.1 Urinary Follicle Stimulating Hormone Sales Channels

7.4.2 Urinary Follicle Stimulating Hormone Distributors

7.5 Urinary Follicle Stimulating Hormone Customer Analysis

8 Urinary Follicle Stimulating Hormone Market Dynamics

8.1 Urinary Follicle Stimulating Hormone Industry Trends

8.2 Urinary Follicle Stimulating Hormone Market Drivers

8.3 Urinary Follicle Stimulating Hormone Market Challenges

8.4 Urinary Follicle Stimulating Hormone Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

IBSA

Ferring

LIVZON

List of Tables

Table 1. Global Urinary Follicle Stimulating Hormone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Urinary Follicle Stimulating Hormone Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Urinary Follicle Stimulating Hormone Market Competitive Situation by Manufacturers in 2024

Table 4. Global Urinary Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2020-2025)

Table 5. Global Urinary Follicle Stimulating Hormone Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Urinary Follicle Stimulating Hormone Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Urinary Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Urinary Follicle Stimulating Hormone, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Product Type & Application

Table 12. Global Key Manufacturers of Urinary Follicle Stimulating Hormone, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Urinary Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Follicle Stimulating Hormone as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Urinary Follicle Stimulating Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Urinary Follicle Stimulating Hormone Sales by Region (2020-2025) & (K Doses)

Table 18. Global Urinary Follicle Stimulating Hormone Sales Market Share by Region (2020-2025)

Table 19. Global Urinary Follicle Stimulating Hormone Sales by Region (2026-2031) & (K Doses)

Table 20. Global Urinary Follicle Stimulating Hormone Sales Market Share by Region (2026-2031)

Table 21. Global Urinary Follicle Stimulating Hormone Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Region (2020-2025)

Table 23. Global Urinary Follicle Stimulating Hormone Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Region (2026-2031)

Table 25. North America Urinary Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Urinary Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)

Table 27. North America Urinary Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)

Table 28. North America Urinary Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Urinary Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Urinary Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Urinary Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)

Table 32. Europe Urinary Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)

Table 33. Europe Urinary Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Urinary Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Urinary Follicle Stimulating Hormone Sales by Region (2020-2025) & (K Doses)

Table 37. Asia Pacific Urinary Follicle Stimulating Hormone Sales by Region (2026-2031) & (K Doses)

Table 38. Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Urinary Follicle Stimulating Hormone Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Urinary Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)

Table 42. Latin America Urinary Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)

Table 43. Latin America Urinary Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Urinary Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Urinary Follicle Stimulating Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2020-2025) & (K Doses)

Table 47. Middle East and Africa Urinary Follicle Stimulating Hormone Sales by Country (2026-2031) & (K Doses)

Table 48. Middle East and Africa Urinary Follicle Stimulating Hormone Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Urinary Follicle Stimulating Hormone Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2020-2025)

Table 51. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Type (2026-2031)

Table 52. Global Urinary Follicle Stimulating Hormone Sales Market Share by Type (2020-2025)

Table 53. Global Urinary Follicle Stimulating Hormone Sales Market Share by Type (2026-2031)

Table 54. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Type (2020-2025)

Table 57. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Type (2026-2031)

Table 58. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Type (2020-2025)

Table 59. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Type (2026-2031)

Table 60. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Application (2020-2025)

Table 61. Global Urinary Follicle Stimulating Hormone Sales (K Doses) by Application (2026-2031)

Table 62. Global Urinary Follicle Stimulating Hormone Sales Market Share by Application (2020-2025)

Table 63. Global Urinary Follicle Stimulating Hormone Sales Market Share by Application (2026-2031)

Table 64. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Urinary Follicle Stimulating Hormone Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Application (2020-2025)

Table 67. Global Urinary Follicle Stimulating Hormone Revenue Market Share by Application (2026-2031)

Table 68. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Application (2020-2025)

Table 69. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Application (2026-2031)

Table 70. IBSA Company Information

Table 71. IBSA Description and Business Overview

Table 72. IBSA Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. IBSA Urinary Follicle Stimulating Hormone Product

Table 74. IBSA Recent Developments/Updates

Table 75. Ferring Company Information

Table 76. Ferring Description and Business Overview

Table 77. Ferring Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 78. Ferring Urinary Follicle Stimulating Hormone Product

Table 79. Ferring Recent Developments/Updates

Table 80. Livzon Company Information

Table 81. Livzon Description and Business Overview

Table 82. Livzon Urinary Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 83. Livzon Urinary Follicle Stimulating Hormone Product

Table 84. Livzon Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Urinary Follicle Stimulating Hormone Distributors List

Table 88. Urinary Follicle Stimulating Hormone Customers List

Table 89. Urinary Follicle Stimulating Hormone Market Trends

Table 90. Urinary Follicle Stimulating Hormone Market Drivers

Table 91. Urinary Follicle Stimulating Hormone Market Challenges

Table 92. Urinary Follicle Stimulating Hormone Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Urinary Follicle Stimulating Hormone

Figure 2. Global Urinary Follicle Stimulating Hormone Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Urinary Follicle Stimulating Hormone Market Share by Type: 2024 & 2031

Figure 4. 75IU Product Picture

Figure 5. 150IU Product Picture

Figure 6. Others Product Picture

Figure 7. Global Urinary Follicle Stimulating Hormone Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Urinary Follicle Stimulating Hormone Market Share by Application: 2024 & 2031

Figure 9. Infertility Treatment

Figure 10. Assisted Reproductive Technology

Figure 11. Global Urinary Follicle Stimulating Hormone Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Urinary Follicle Stimulating Hormone Market Size (2020-2031) & (US$ Million)

Figure 13. Global Urinary Follicle Stimulating Hormone Sales (2020-2031) & (K Doses)

Figure 14. Global Urinary Follicle Stimulating Hormone Average Price (USD/Dose) & (2020-2031)

Figure 15. Urinary Follicle Stimulating Hormone Report Years Considered

Figure 16. Urinary Follicle Stimulating Hormone Sales Share by Manufacturers in 2024

Figure 17. Global Urinary Follicle Stimulating Hormone Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Urinary Follicle Stimulating Hormone Players: Market Share by Revenue in Urinary Follicle Stimulating Hormone in 2024

Figure 19. Urinary Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Urinary Follicle Stimulating Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Urinary Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)

Figure 22. North America Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)

Figure 23. United States Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Urinary Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)

Figure 26. Europe Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)

Figure 27. Germany Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Urinary Follicle Stimulating Hormone Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Urinary Follicle Stimulating Hormone Revenue Market Share by Region (2020-2031)

Figure 34. China Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Urinary Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)

Figure 44. Latin America Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Urinary Follicle Stimulating Hormone Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Urinary Follicle Stimulating Hormone Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Urinary Follicle Stimulating Hormone Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Urinary Follicle Stimulating Hormone by Type (2020-2031)

Figure 54. Global Revenue Market Share of Urinary Follicle Stimulating Hormone by Type (2020-2031)

Figure 55. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Type (2020-2031)

Figure 56. Global Sales Market Share of Urinary Follicle Stimulating Hormone by Application (2020-2031)

Figure 57. Global Revenue Market Share of Urinary Follicle Stimulating Hormone by Application (2020-2031)

Figure 58. Global Urinary Follicle Stimulating Hormone Price (USD/Dose) by Application (2020-2031)

Figure 59. Urinary Follicle Stimulating Hormone Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024

Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Follicle Stimulating Hormone FSH ELISA Test Kit Market Research Report 2024

Global Recombinant FSH Injections Market Research Report 2024

Global Menotropin Market Research Report 2024

Recombinant Human Follicle stimulating Hormone Market

Global Follicle Stimulating Hormone Test Kit Market Research Report 2024

Global Fertility and Pregnancy Rapid Test Kits Market Research Report 2025

Global Veterinary Follicle Stimulating Hormones FSH Market Research Report 2024

Global Diagnostic Kit for Luteinizing Hormone Market Research Report 2024

Fertility Test Rapid Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pregnancy and Fertility Testing Kits Market Insights Forecast to 2030

Human Chorionic Gonadotropin HCG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global FSH Test Kit Market Research Report 2024

Global Ovulation Test Kit Market Research Report 2024

Follitropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pregnancy Tests Market Research Report 2024

Global Natural Conjugated Estrogens API Market Research Report 2024

Global Follicle Aspiration Sets Market Insights Forecast to 2030

RELATED REPORTS

Global Breast Shell Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24P9375

Thu Sep 04 00:00:00 UTC 2025

Add to Cart

Global Bioidentical Hormones Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35B6852

Tue Sep 02 00:00:00 UTC 2025

Add to Cart

Global Organic Baby Bathing Product Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0W11645

Sat Aug 30 00:00:00 UTC 2025

Add to Cart

Global Blue LED Infant Phototherapy Lamp Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19D13935

Wed Aug 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions